You'll earn the same rewards and sign-up bonus as on Southwest's pricier cards, but you'll also miss out on a couple of important benefits. This page includes information about the Southwest Rapid ...

A phase 1 trial of pembrolizumab plus denileukin diftitox shows 27% response and 33% clinical benefit in recurrent solid tumors, with manageable toxicity. A regimen of pembrolizumab (Keytruda) and ...